CCT3 and Miyoshi myopathy: In this study, the authors found that silencing of circular RNA chaperonin containing TCP1 subunit 3 (circ-CCT3) enhanced the sensitivity of bortezomib-resistant MM cells to bortezomib via modulating miR-223-3p.